Resources Contact Us Home
Recombinant toxin fragments

Image Number 4 for United States Patent #8017134.

A single polypeptide is provided which comprises first and second domains. The first domain enables the polypeptide to cleave one or more vesicle or plasma-membrane associated proteins essential to exocytosis, and the second domain enables the polypeptide to be translocated into a target cell or increases the solubility of the polypeptide, or both. The polypeptide thus combines useful properties of a clostridial toxin, such as a botulinum or tetanus toxin, without the toxicity associated with the natural molecule. The polypeptide can also contain a third domain that targets it to a specific cell, rendering the polypeptide useful in inhibition of exocytosis in target cells. Fusion proteins comprising the polypeptide, nucleic acids encoding the polypeptide and methods of making the polypeptide are also provided. Controlled activation of the polypeptide is possible and the polypeptide can be incorporated into vaccines and toxin assays.

  Recently Added Patents
Memory device and method for dynamic random access memory having serial interface and integral instruction buffer
Fuser member having composite outer layer
Playback device, playback method, and computer program
Flexible organic light emitting device and manufacturing method thereof
Synthesized interoperable communications
Display apparatus
  Randomly Featured Patents
Arrangement for discharging liquid medium under high pressure
Skin protection compositions, in particular cream to protect against cold
Non-dispersive process for insoluble oil recovery from aqueous slurries
Hydrostatic, slow actuating subterranean well tool manipulation device and method
Efficient under color removal
Foldable cantilever
Method and apparatus for providing single instance restoration of data files
Method of producing a tool component
Complexes and compositions for magnetic resonance imaging and usage methods
2-(arylalkoxy)-1-phenylethylamine derivatives as NK.sub.1 antagonist and serotonin reuptake inhibitors